Cara Therapeutics Inc (CARA)
0.6599
-0.03
(-4.36%)
USD |
NASDAQ |
Apr 19, 11:39
Cara Therapeutics Total Return Price: 0.6599 for April 19, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| April 18, 2024 | 0.69 |
| April 17, 2024 | 0.7319 |
| April 16, 2024 | 0.709 |
| April 15, 2024 | 0.71 |
| April 12, 2024 | 0.7641 |
| April 11, 2024 | 0.8106 |
| April 10, 2024 | 0.812 |
| April 09, 2024 | 0.832 |
| April 08, 2024 | 0.8255 |
| April 05, 2024 | 0.8745 |
| April 04, 2024 | 0.8258 |
| April 03, 2024 | 0.9074 |
| April 02, 2024 | 0.9195 |
| April 01, 2024 | 0.91 |
| March 28, 2024 | 0.91 |
| March 27, 2024 | 0.869 |
| March 26, 2024 | 0.7302 |
| March 25, 2024 | 0.8199 |
| March 22, 2024 | 0.8833 |
| March 21, 2024 | 0.8916 |
| March 20, 2024 | 0.9028 |
| March 19, 2024 | 0.89 |
| March 18, 2024 | 0.9074 |
| March 15, 2024 | 0.8781 |
| March 14, 2024 | 0.7865 |
| Date | Value |
|---|---|
| March 13, 2024 | 0.8702 |
| March 12, 2024 | 0.88 |
| March 11, 2024 | 0.9499 |
| March 08, 2024 | 0.9814 |
| March 07, 2024 | 1.05 |
| March 06, 2024 | 0.9901 |
| March 05, 2024 | 0.91 |
| March 04, 2024 | 0.9998 |
| March 01, 2024 | 0.95 |
| February 29, 2024 | 0.8502 |
| February 28, 2024 | 0.89 |
| February 27, 2024 | 0.9455 |
| February 26, 2024 | 0.8011 |
| February 23, 2024 | 0.9071 |
| February 22, 2024 | 0.7988 |
| February 21, 2024 | 0.6762 |
| February 20, 2024 | 0.6423 |
| February 16, 2024 | 0.6262 |
| February 15, 2024 | 0.5953 |
| February 14, 2024 | 0.5651 |
| February 13, 2024 | 0.5332 |
| February 12, 2024 | 0.583 |
| February 09, 2024 | 0.5658 |
| February 08, 2024 | 0.5201 |
| February 07, 2024 | 0.5323 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
0.5201
Minimum
Feb 08 2024
29.19
Maximum
Apr 09 2021
12.18
Average
12.78
Median
Jul 20 2021
Total Return Price Benchmarks
| Nektar Therapeutics | 1.285 |
| Stereotaxis Inc | 2.51 |
| Cerus Corp | 1.67 |
| Avid Bioservices Inc | 6.34 |
| Rigel Pharmaceuticals Inc | 1.055 |